How to use the search function
3 documents found
R & D report
Optimization of conservative treatment of HER2 / neu breast cancer patients (negative) at high risk of disease progression.
1
Head: Syvak Lubov А.. Optimization of conservative treatment of HER2 / neu breast cancer patients (negative) at high risk of disease progression.. (popup.stage: ). National Cancer Institute. № 0222U003718
R & D report
Optimization of conservative treatment of HER2 / neu breast cancer patients (negative) at high risk of disease progression.
Head: Syvak Lubov А.. Optimization of conservative treatment of HER2 / neu breast cancer patients (negative) at high risk of disease progression.. (popup.stage: ). National Cancer Institute. № 0221U104838
R & D report
To optimize treatment in patients with metastatic breast cancer molecular subtypes adverse prognostic
Head: Syvak Lubov А.. To optimize treatment in patients with metastatic breast cancer molecular subtypes adverse prognostic. (popup.stage: ). National Cancer Institute. № 0220U102648
3 documents found

Updated: 2026-10-22


Роздрукувати цю сторінку